William Lewis - Jan 8, 2024 Form 4 Insider Report for INSMED Inc (INSM)

Role
Chair and CEO, Director
Signature
/s/ William Lewis, by Michael A. Smith as Attorney in Fact
Stock symbol
INSM
Transactions as of
Jan 8, 2024
Transactions value $
$236,090
Form type
4
Date filed
1/10/2024, 04:15 PM
Previous filing
Jan 8, 2024
Next filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Options Exercise $511K +25K +6.68% $20.49 398K Jan 8, 2024 Direct F1
transaction INSM Common Stock Sale -$726K -25K -6.26% $29.11 374K Jan 8, 2024 Direct F1, F2
transaction INSM Common Stock Options Exercise $413K +20.2K +5.4% $20.49 394K Jan 8, 2024 Direct F1
transaction INSM Common Stock Sale -$603K -20.2K -5.12% $29.88 374K Jan 8, 2024 Direct F1, F3
transaction INSM Common Stock Sale -$284K -9.89K -2.65% $28.72 364K Jan 9, 2024 Direct F4, F5
holding INSM Common Stock 234K Jan 8, 2024 By ARTICLE 4 KATIE PROCTER DYNASTY TRUST
holding INSM Common Stock 500 Jan 8, 2024 By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Options Exercise $925K +45.1K $20.49 0 Jan 8, 2024 Common Stock 45.1K $20.49 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 This is the weighted average sales price representing 24,951 shares sold at prices ranging from $28.71 to $29.68 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3 This is the weighted average sales price representing 20,169 shares sold at prices ranging from $29.88 to $29.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4 Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
F5 This is the weighted average sales price representing 9,887 shares sold at prices ranging from $28.62 to $28.84 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F6 Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. All options are currently exercisable and were scheduled to expire on January 10, 2024.